Detection of p-chloroamphetamine in urine samples with mass spectrometry

Journal of Analytical Toxicology

Volumn 35, Issue 4, 2011, Pages 205-210

  Lin, Tsz C ^a   Lin, Dong Liang ^b   Lua, Ahai C ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b MINISTRY OF JUSTICE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CHLORAMPHETAMINE; EPHEDRINE; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; TRIFLUOROACETIC ANHYDRIDE;

ACCURACY; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; IMMUNOASSAY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; QUALITY CONTROL; URINALYSIS;

EID: 79954612207     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/anatox/35.4.205     Document Type: Article

References (21)

1. K.L. Klette, A.R. Kettle, and M.H. Jamerson. Prevalence of use for amphetamine (AMP), methamphetamine (MAMP), 3,4-methylene-dioxyamphetamine (MDA), 3,4-methylenedioxymetham-phetamine (MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) in military entrance processing stations (MEPS) speci-mens. J. Anal. Toxicol. 30: 319-322 (2006).
2. B.K. Logan. Amphetamines: an update on forensic issues. J. Anal. Toxicol. 25: 400-404 (2001).
3. D.M. Stone, M. Johnson, G.R. Hanson, and J.W. Gibb. A com-parison of the neurotoxic potential of methylenedioxyam-phetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur. J. Pharmacol. 134: 245-248 (1987).
4. M. Nieddu, G. Boatto, M.A. Pirisi, and E. Baralla. Multi-residue analysis of eight thioamphetamine designer drugs in human urine by liquid chromatography/tandem mass spectrometry. Rapid Comm. Mass. Spectrom. 23: 3051-3056 (2009).
5. R.F. Staack, J. Fehn, and H.H. Maurer. New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. J. Chromatogr. B 789: 27-41 (2003).
6. A.M. Dipietra, R. Gotti, E. Del Borrello, R. Pomponio, and V. Cavrini. Analysis of amphetamine and congeners in illicit samples by liquid chromatography and capillary electrophoresis. J. Anal. Toxicol. 25: 99-105 (2001).
7. K. Zaitsu, M. Katagi, H.T. Kamata, T. Kamata, N. Shima, A. Miki, H. Tsuchihashi, and Y. Mori. Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine. Forensic Sci. Int. 18: 131-139 (2009).
8. Department of Health and Human Services. Substance Abuse and Mental Services Administration. Mandatory Guidelines and proposed revisions to mandatory for federal workplace drug testing programs. Fed. Regist. 69: 19644-19673 (2004).
9. M.H. Hung, R.H. Liu, Y.L. Chen, and S.L. Rhodes. Correlation of drug-testing results-immunoassay versus gas chromatography-mass spectrometry. Forensic Sci. Rev. 18: 9-41 (2006).
10. G. Frison, L. Tedeschi, D. Favretto, A. Reheman, and S.D. Ferrara. Gas chromatography/mass spectrometry determination of amphetamine-related drugs and ephedrine in plasma, urine and hair samples after derivatization with 2,2,2-trichloroethyl chlorofor-mate. Rapid Comm. Mass Spectrom. 19: 919-927 (2005).
11. C.L. Hornbeck and R.J. Czarny. Quantitation of metham-phetamine and amphetamine in urine by capillary GC/MS. Part I. Advantages of trichloroacetyl derivatization. J. Anal. Toxicol. 13: 144-149 (1989).
12. M.R. Moeller, P. Frey, and R. Wenning. Simultaneous determina-tion of drugs of abuse (opiates, cocaine and amphetamine) in human hair by GC/MS and its application to a methadone treat-ment program. Forensic Sci. Int. 63: 185-206 (1993).
13. P.R. Stout, C.K. Horn, and K.L. Klette. Rapid simultaneous deter-mination of amphetamine, methamphetamine, 3,4-methylene-dioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by solid-phase extraction and GC-MS: a method optimized for high-volume laboratories. J. Anal. Toxicol. 26: 253-261 (2002).
14. J. Jonsson, R. Kronstrand, and M. Hatanpaa. Convenient deriva-tization method for the determination of amphetamine and related drugs in urine. J. Forensic Sci. 41: 148-151 (1996).
15. H.C. Liu, R.H. Liu, H.O. Ho, and D.L. Lin. Development of an in-formation-rich LC-MS/MS database for the analysis of drugs in postmortem specimens. Anal. Chem. 81: 9002-9011 (2009).
16. H.R. Lin and A.C. Lua. Simultaneous determination of am-phetamines and ketamines in urine by gas chromatography/mass spectrometry. Rapid Comm. Mass Spectrom. 20: 1724-1730 (2006).
17. J.E. Owen, Jr. Psychopharmacological studies of some 1-(chlorophenyl)-2-aminopropanes. I. Effects on appetitive-con-trolled behavior. J. Pharm. Sci. 52: 679-683 (1963).
18. J.E. Owen, Jr. Psychopharmacological studies of some 1-(chlorophenyl)-2-aminopropanes. II. Effects on avoidance and discrimination behavior. J. Pharm. Sci. 52: 684-688 (1963).
19. R.W. Fuller. Effects of p-chloroamphetamine on brain serotonin neurons. Neurochem. Res. 17: 449-456 (1992).
20. Y. Itzhak, C.N. Achat-Mendes, S.F. Ali, and K.L. Anderson. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice. Neuropharmacology 46: 74-84 (2004).
21. Y. Itzhak and S.F. Ali. Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs. Pharmacol. Ther. 109: 246-262 (2006).